Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles up 2% after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Revolution Medicines prices RASONQUE at $39,800 per month
Cardinal Health (CAH) PT Lowered to $77 at Cowen Following 4Q Report
August 2, 2017 4:05 PM EDTCowen lowered its price target on Cardinal Health (NYSE: CAH) to $77.00 (from $82.00) while maintaining a Market Perform rating. CAH reported adjusted EPS of $1.31 that was above the consensus estimates of $1.24, but would have missed without a tax benefit.
Management announced F2018 adjusted EPS... More
Cardinal Health (CAH) Tops Q4 EPS by 7c; Guides Short of Views
August 2, 2017 7:02 AM EDTCardinal Health (NYSE: CAH) reported Q4 EPS of $1.31, $0.07 better than the analyst estimate of $1.24. Revenue for the quarter came in at $33 billion versus the consensus estimate of $32.73 billion.
GUIDANCE:
Cardinal Health sees FY2018 EPS of $4.85-$5.10, versus the consensus of... More
